LBP-9 Activators
LBP-9 activators constitute a group of chemical agents designed to modulate the function of the protein LBP-9, which plays a role in a variety of cellular processes. LBP-9, or Ligand Binding Protein 9, is a protein that is involved in the binding and recognition of specific molecules within the cell, facilitating the transmission of signals that can influence cellular behavior. The precise function of LBP-9 can vary depending on the cellular context, but it generally participates in the intricate network of intracellular signaling pathways.
The activators of LBP-9 can operate through either direct engagement with the protein or by interacting with other molecular components that modulate the activity of LBP-9 indirectly. Direct activators are typically small molecules or peptides that bind to LBP-9 in a manner that induces a conformational change in the protein structure. This alteration in shape can enhance the protein's ability to interact with its natural ligands or partners within the cell, thereby amplifying the downstream signaling events. Indirect activators, on the other hand, may not bind to LBP-9 directly but instead influence other molecules or cellular conditions that affect the function of LBP-9. For instance, an indirect activator might increase the expression levels of LBP-9, augment the stability of the protein, or modify other proteins that regulate LBP-9 activity through post-translational modifications such as phosphorylation, ubiquitination, or sumoylation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate is a histone deacetylase (HDAC) inhibitor that promotes the acetylation of histones, thereby loosening the chromatin structure. This process can enhance the accessibility of transcription factors to the promoter regions of genes, including LBP-9, thereby increasing its transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that prevents DNA methylation, a process often linked to gene silencing. Inhibition of methylation can enhance the expression of LBP-9 if its promoter region is normally methylated. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that promotes acetylation of histones, loosening the chromatin structure and enhancing gene transcription. It can increase the transcription of LBP-9 by affecting chromatin structure. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A inhibits SP1, a transcription factor that binds to GC-rich promoter regions. If SP1 negatively regulates LBP-9, inhibition of SP1 can enhance the expression of LBP-9. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits topoisomerase II, leading to DNA damage and the activation of the p53 pathway. If LBP-9 transcription is under the control of p53, Etoposide can potentially enhance LBP-9 expression via p53 pathway activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, leading to the activation of PKA. If LBP-9 is a target of PKA, Forskolin can promote LBP-9 activity via PKA pathway activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid is a ligand for the retinoic acid receptor (RAR), which modulates gene expression. If LBP-9 is a target of RAR, Retinoic Acid can enhance the transcription of LBP-9 via RAR activation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid receptor agonist. If LBP-9 is a target of the glucocorticoid receptor, Dexamethasone can enhance the transcription of LBP-9 via glucocorticoid receptor activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and proliferation. If LBP-9 is a target of mTOR, Rapamycin can enhance the expression of LBP-9 in response to mTOR inhibition. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK3, a kinase involved in various signaling pathways. If LBP-9 is a target of GSK3, its expression can be enhanced in response to GSK3 inhibition. | ||||||